<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">

  <!-- PACE Progress Bar START -->
  
    
<script src="https://raw.githubusercontent.com/HubSpot/pace/v1.0.2/pace.min.js"></script>

    
<link rel="stylesheet" href="https://github.com/HubSpot/pace/raw/master/themes/orange/pace-theme-flash.css">

  
  

  <!-- PACE Progress Bar START -->

  
  <title>Hexo</title>
  <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
  
  
  
  
  <meta name="description" content="A second vaccine against covid-19 arrives第二种针对covid-19的疫苗问世了 Getting better all the time 一直在好转 ![image-20201128110012040](&#x2F;Users&#x2F;chenyujie&#x2F;Library&#x2F;Application Support&#x2F;typora-u">
<meta property="og:type" content="article">
<meta property="og:title" content="Hexo">
<meta property="og:url" content="http://example.com/2020/11/28/Day222-The%20Economist/index.html">
<meta property="og:site_name" content="Hexo">
<meta property="og:description" content="A second vaccine against covid-19 arrives第二种针对covid-19的疫苗问世了 Getting better all the time 一直在好转 ![image-20201128110012040](&#x2F;Users&#x2F;chenyujie&#x2F;Library&#x2F;Application Support&#x2F;typora-u">
<meta property="og:locale" content="en_US">
<meta property="article:published_time" content="2020-11-28T02:58:37.944Z">
<meta property="article:modified_time" content="2020-11-28T03:00:43.222Z">
<meta property="article:author" content="John Doe">
<meta name="twitter:card" content="summary">
  
    <link rel="alternate" href="/atom.xml" title="Hexo" type="application/atom+xml">
  
  <link rel="icon" href="/css/images/favicon.ico">
  
    <link href="//fonts.googleapis.com/css?family=Source+Code+Pro" rel="stylesheet" type="text/css">
  
  <link href="https://fonts.googleapis.com/css?family=Open+Sans|Montserrat:700" rel="stylesheet" type="text/css">
  <link href="https://fonts.googleapis.com/css?family=Roboto:400,300,300italic,400italic" rel="stylesheet" type="text/css">
  <link href="https://cdn.bootcss.com/font-awesome/4.6.3/css/font-awesome.min.css" rel="stylesheet">
  <style type="text/css">
    @font-face{font-family:futura-pt;src:url(https://use.typekit.net/af/9749f0/00000000000000000001008f/27/l?subset_id=2&fvd=n5) format("woff2");font-weight:500;font-style:normal;}
    @font-face{font-family:futura-pt;src:url(https://use.typekit.net/af/90cf9f/000000000000000000010091/27/l?subset_id=2&fvd=n7) format("woff2");font-weight:500;font-style:normal;}
    @font-face{font-family:futura-pt;src:url(https://use.typekit.net/af/8a5494/000000000000000000013365/27/l?subset_id=2&fvd=n4) format("woff2");font-weight:lighter;font-style:normal;}
    @font-face{font-family:futura-pt;src:url(https://use.typekit.net/af/d337d8/000000000000000000010095/27/l?subset_id=2&fvd=i4) format("woff2");font-weight:400;font-style:italic;}</style>
    
  <link rel="stylesheet" id="athemes-headings-fonts-css" href="//fonts.googleapis.com/css?family=Yanone+Kaffeesatz%3A200%2C300%2C400%2C700&amp;ver=4.6.1" type="text/css" media="all">
  
<link rel="stylesheet" href="/css/style.css">


  
<script src="https://code.jquery.com/jquery-3.1.1.min.js"></script>


  <!-- Bootstrap core CSS -->
  <link rel="stylesheet" href="https://netdna.bootstrapcdn.com/bootstrap/3.0.2/css/bootstrap.min.css" >
  <link rel="stylesheet" href="/css/hiero.css" >
  <link rel="stylesheet" href="/css/glyphs.css" >
  
    <link rel="stylesheet" href="/css/vdonate.css" >
  

  <!-- Custom CSS -->
  
<link rel="stylesheet" href="/css/my.css">

  <!-- Google Adsense -->
  
  <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
  <script>
      (adsbygoogle = window.adsbygoogle || []).push({
          google_ad_client: "ca-pub-0123456789ABCDEF",
          enable_page_level_ads: true
      });
  </script>
  
<meta name="generator" content="Hexo 6.3.0"></head>

<script>
var themeMenus = {};

  themeMenus["/"] = "Home"; 

  themeMenus["/archives"] = "Archives"; 

  themeMenus["/categories"] = "Categories"; 

  themeMenus["/tags"] = "Tags"; 

  themeMenus["/about"] = "About"; 

</script>


  <body data-spy="scroll" data-target="#toc" data-offset="50">


  <header id="allheader" class="site-header" role="banner">
  <div class="clearfix container">
      <div class="site-branding">

          <h1 class="site-title">
            
              <a href="/" title="Hexo" rel="home"> Hexo </a>
            
          </h1>

          
            
          <nav id="main-navigation" class="main-navigation" role="navigation">
            <a class="nav-open">Menu</a>
            <a class="nav-close">Close</a>
            <div class="clearfix sf-menu">

              <ul id="main-nav" class="nmenu sf-js-enabled">
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663"> <a class="" href="/">Home</a> </li>
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663"> <a class="" href="/archives">Archives</a> </li>
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663"> <a class="" href="/categories">Categories</a> </li>
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663"> <a class="" href="/tags">Tags</a> </li>
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663"> <a class="" href="/about">About</a> </li>
                    
              </ul>
            </div>
          </nav>


      </div>
  </div>
</header>


  <div id="originBgDiv" style="background: #fff; width: 100%;">

      <div style="max-height:600px; overflow: hidden;  display: flex; display: -webkit-flex; align-items: center;">
        <img id="originBg" width="100%" alt="" src="">
      </div>

  </div>

  <script>
  function setAboutIMG(){
      var imgUrls = "css/images/pose.jpg,https://source.unsplash.com/collection/954550/1920x1080".split(",");
      var random = Math.floor((Math.random() * imgUrls.length ));
      if (imgUrls[random].startsWith('http') || imgUrls[random].indexOf('://') >= 0) {
        document.getElementById("originBg").src=imgUrls[random];
      } else {
        document.getElementById("originBg").src='/' + imgUrls[random];
      }
  }
  bgDiv=document.getElementById("originBgDiv");
  if(location.pathname.match('about')){
    setAboutIMG();
    bgDiv.style.display='block';
  }else{
    bgDiv.style.display='none';
  }
  </script>



  <div id="container">
    <div id="wrap">
            
      <div id="content" class="outer">
        
          <section id="main" style="float:none;"><article id="post-Day222-The Economist" style="width: 66%; float:left;" class="article article-type-post" itemscope itemprop="blogPost" >
  <div id="articleInner" class="clearfix post-1016 post type-post status-publish format-standard has-post-thumbnail hentry category-template-2 category-uncategorized tag-codex tag-edge-case tag-featured-image tag-image tag-template">
    
    
    <div class="article-meta">
      
	Posted on <a href="/2020/11/28/Day222-The%20Economist/" class="article-date">
	  <time datetime="2020-11-28T02:58:37.944Z" itemprop="datePublished">November 28, 2020</time>
	</a>

      
	<span id="busuanzi_container_page_pv">
	  本文总阅读量<span id="busuanzi_value_page_pv"></span>次
	</span>

    </div>
    <div class="article-entry" itemprop="articleBody">
      
        <h1 id="A-second-vaccine-against-covid-19-arrives"><a href="#A-second-vaccine-against-covid-19-arrives" class="headerlink" title="A second vaccine against covid-19 arrives"></a>A second vaccine against covid-19 arrives</h1><p>第二种针对covid-19的疫苗问世了</p>
<h6 id="Getting-better-all-the-time-一直在好转-image-20201128110012040-Users-chenyujie-Library-Application-Support-typora-user-images-image-20201128110012040-png"><a href="#Getting-better-all-the-time-一直在好转-image-20201128110012040-Users-chenyujie-Library-Application-Support-typora-user-images-image-20201128110012040-png" class="headerlink" title="Getting better all the time 一直在好转 ![image-20201128110012040](&#x2F;Users&#x2F;chenyujie&#x2F;Library&#x2F;Application Support&#x2F;typora-user-images&#x2F;image-20201128110012040.png)"></a>Getting better all the time 一直在好转 ![image-20201128110012040](&#x2F;Users&#x2F;chenyujie&#x2F;Library&#x2F;Application Support&#x2F;typora-user-images&#x2F;image-20201128110012040.png)</h6><h5 id="And-there-are-surely-more-to-come-肯定还会有更多"><a href="#And-there-are-surely-more-to-come-肯定还会有更多" class="headerlink" title="And there are surely more to come 肯定还会有更多"></a>And there are surely more to come 肯定还会有更多</h5><blockquote>
<p>Nov 19th 2020 </p>
</blockquote>
<p><strong>WAITING FOR a breakthroug</strong>h <em>in the fight against covid-19</em> has been a bit like waiting for a bus to arrive. After almost a year of <strong>watch-checking</strong> and <strong>neck-craning</strong>, two <strong>come along</strong> at once. First, on November 9th, Pfizer, an American pharma giant and BioNTech, a German minnow, announced that they had <em>jointly developed</em> an effective vaccine for the illness. They were followed, on November 16th, by Moderna, an American biotech firm.</p>
<blockquote>
<p>Come along 出现</p>
<p>Pharma 制药业</p>
<p>minnow 无足轻重的人；无足轻重的公司 ; 不起眼的运动队</p>
</blockquote>
<p>等待抗击covid-19取得突破有点像等待一辆巴士到来。经过将近一年的观察和摸索，两件事同时出现了。首先，11月9日，美国制药巨头辉瑞公司(Pfizer)和德国小公司生物科技(BioNTech)宣布，他们已联合开发出一种针对这种疾病的有效疫苗。11月16日，美国生物技术公司Moderna紧随其后。</p>
<p>Moderna says its offering is 94.5% effective. Pfizer says the efficacy of its is 95%. Moderna’s figure is an estimate based on a peek at data being gathered in a continuing trial involving 30,000 volunteers. Pfizer’s comes from the final analysis of a trial involving 43,000 people, in which 170 cases of covid-19 were seen. Of these, 162 were in the placebo arm (ie, those involved had received dummy injections).</p>
<blockquote>
<p>placebo 安慰剂 ; 无效对照剂</p>
<p>dummy 人体模型 ; 仿制品 ; 仿造物 ; 笨蛋 ; 蠢货 ; 假的</p>
</blockquote>
<p>Moderna表示，其产品的有效利率为94.5%。辉瑞公司称其功效为95%。Moderna的数据是基于对一项持续试验中收集的数据的粗略估计，该试验涉及3万名志愿者。辉瑞的结论来自对一项涉及43,000人的试验的最终分析，其中170例covid-19感染病例。其中162人属于安慰剂组(即接受了假注射的组)。</p>
<p>The news <strong>bodes well for</strong> a third candidate, from AstraZeneca and Oxford University. This pair have, <strong>rather notably</strong>, not released any <em>interim data</em> from their trials so far. <strong>They have also been vaguer about</strong> when their vaccine might be available, saying only, “the end of the year”. <strong>But it is thought</strong> their trials are only weeks away from having a full set of data. Mene Pangalos, AstraZeneca’s head of R&amp;D, told the Greenwich Economic Forum, a conference held last week, that the firm might <strong>apply for full approval</strong>—rather than the emergency authorisation sought by the other two projects—in America, and perhaps in Britain and other parts of Europe as well.</p>
<blockquote>
<p>Bode well&#x2F;ill（for sth&#x2F;sb）</p>
<p>(对某事物&#x2F;某人)是吉兆&#x2F;凶兆</p>
</blockquote>
<p>这一消息对来自阿斯利康和牛津大学的第三位候选人来说是个好兆头。值得注意的是，到目前为止，这对搭档还没有公布他们试验的任何中期数据。他们也对疫苗何时能上市含糊其辞，只说“年底”。但人们认为，他们的试验距离获得完整的数据只有几周的时间。阿斯利康研发部主管Mene Pangalos在上周举行的格林威治经济论坛上表示，阿斯利康公司可能会在美国、或许还有英国和欧洲其他地区申请全面批准，而不是像其他两个项目那样申请紧急授权。</p>
<p><strong>More good news was to be found</strong> <em>among the details of how</em>, <em>and for whom</em>, these vaccines work. All the severe cases of covid were seen in unvaccinated volunteers. <strong>It is also now clear that</strong> the vaccines worked in participants of <strong>a range of ages</strong>, including those over 65, and <strong>from a variety of</strong> ethnic backgrounds. This means both vaccines will save lives <strong>in groups of</strong> people who have been <strong>hit disproportionately hard</strong> by covid-19. Data published this week in the Lancet suggest that the elderly respond well to the AstraZeneca vaccine, too. Continuing reviews of the safety of these vaccines suggest they are <strong>well tolerated</strong>, although a minority do get a day of flu-like symptoms, such as fatigue, muscle and joint pain.</p>
<p>更多的好消息是在这些疫苗如何以及对谁起作用的细节中发现的。所有严重的covid病例都出现在未接种疫苗的志愿者身上。现在也清楚的是，疫苗对不同年龄的参与者都有效，包括65岁以上的人和来自不同种族背景的人。这意味着，这两种疫苗都将拯救严重感染covid-19的人群的生命。本周发表在《柳叶刀》杂志上的数据表明，老年人对阿斯利康疫苗的反应也很好。对这些疫苗安全性的持续研究表明，它们具有良好的耐受性，尽管少数人确实出现一天类似流感的症状，如疲劳、肌肉和关节疼痛。</p>
<p>The first two vaccines both look like <strong>worthy weapons</strong> <em>in the fight against</em> covid-19. <strong>There i</strong>s, though, <strong>one thing abou</strong>t the Moderna vaccine <strong>that sets it apart.</strong> It can be kept in a regular fridge at between 2°C and 8°C for 30 days. The Pfizer vaccine, <strong>by contrast</strong>, needs to be kept ultracold, at -70°C or below, <strong>most of the time</strong>. That will make the Moderna vaccine <strong>far easier and cheaper</strong> to distribute (although the cost of the Moderna vaccine itself is higher). If the AstraZeneca vaccine <strong>proves successful</strong>, <strong>it</strong>, too, <strong>is thought likely to</strong> need only a standard refrigerator to preserve it. And because this vaccine is also <strong>a fraction of the price of</strong> the others, it might still <strong>end up being</strong> <strong>the most popular choice.</strong></p>
<blockquote>
<p>Set apart 使与众不同</p>
<p>What sets her apart is the elegance of her prose style.</p>
<p>她的散文风格典雅，使她的写作独具特色。 </p>
</blockquote>
<p>前两种疫苗看起来都是抗击covid-19的有效武器。然而，Moderna的疫苗有一点与众不同。它可以在2 - 8摄氏度的普通冰箱中保存30天。相比之下，辉瑞的疫苗需要保持低温，大部分时间在-70℃或以下。这将使Moderna疫苗的分销更容易、更便宜(尽管Moderna疫苗本身的成本更高)。如果阿斯利康的疫苗被证明是成功的，它也被认为可能只需要一个标准的冰箱来保存它。而且由于这种疫苗的价格只是其他疫苗的一小部分，因此它可能仍然是最受欢迎的选择。</p>
<p>All three vaccines use the same strategy: to introduce into the human body RNA (a molecule similar to DNA) that carries the recipe for “spike”, a <strong>protein abundant</strong> on the outsides of particles of SARS-CoV-2, the virus that causes covid-19. The body then uses this recipe to manufacture spike, and the immune system, recognising the protein as alien, <strong>mounts a response to it</strong>. Thus stimulated, the immune system can react rapidly if it subsequently encounters the spike proteins of actual viruses.</p>
<blockquote>
<p>刺突蛋白</p>
</blockquote>
<p>背景：目前,全球范围内正在进行的大多数新冠疫苗研究针对的都是刺突蛋白(spike protein)。这种蛋白能刺穿新冠病毒的表面,并让它侵入人体细胞。阻断这种蛋白质, 人们就不会被感染。研究人员复制了新冠病毒遗传密码中包含细胞制造刺突蛋白指令的部分，然后将那些“信使核糖核酸(mRNA)”包装成疫苗。他们的做法是：身体将变成一个小型工厂，生产一些无害的刺突状蛋白质。当免疫系统发现外来蛋白质时，它就会产生抗体进行攻击，并且在以后遇到真正的病毒时，也能迅速做出反应。</p>
<blockquote>
<p>这三种疫苗都采用了相同的策略:将携带“刺突”配方的RNA(一种类似于DNA的分子)引入人体。“刺突”是一种富含SARS-CoV-2病毒颗粒外的蛋白质，SARS-CoV-2是导致covid-19的病毒。然后，人体利用这种配方制造出刺突，免疫系统将这种蛋白质识别为异类，并对其做出反应。在这样的刺激下，当免疫系统随后遇到真正病毒的刺突蛋白时，它可以迅速做出反应。</p>
</blockquote>
<p>The vaccines from Pfizer and Moderna introduce the RNA directly, as molecules known as <strong>messenger RNA</strong> (mRNA) held inside small, fatty particles called liposomes. AstraZeneca’s offering instead incorporates the RNA into the <em>genetic material</em> of a harmless cold virus. The mRNA approach <em>is regarded as</em> particularly interesting, because <strong>this is the first successful example of</strong> what researchers hope will be a new class of drugs that work by feeding cells instructions to make therapeutic proteins <em>in situ</em>.</p>
<blockquote>
<p>messenger RNA 信使 RNA</p>
<p>genetic material 遗传物质</p>
<p>In situ 在原位</p>
<p>Paintings have been left in situ.</p>
<p>画作被留在原地。</p>
</blockquote>
<p>辉瑞和Moderna生产的疫苗直接引入RNA，这种RNA是一种被称为信使RNA (mRNA)的分子，存在于脂质体中的脂肪小颗粒中。相反，阿斯利康的产品将RNA整合到无害感冒病毒的遗传物质中。mRNA的方法被认为是特别有趣的，因为这是第一个成功的例子，研究人员希望这将是一种新的药物，通过向细胞提供指令，在原位制造治疗性蛋白质。</p>
<blockquote>
<p>Message received 接收到的消息</p>
</blockquote>
<p><strong>Learning how to introduce mRNA into the body</strong> <em>without it either being destroyed or stimulating an unhelpful immune response</em> <strong>has been challenging</strong>. These two new vaccines are <strong>the first evidence of</strong> <em>the technology’s potential</em>. Moderna <em>is pursuing</em> mRNA <strong>as the basis for</strong> other vaccines, against such pathogens as cytomegalovirus, influenza, paediatric-respiratory-syncytial virus and Zika. BioNTech, meanwhile, <em>is exploring</em> the use of mRNA to stimulate the immune system to fight cancer. Its pipeline includes treatments for malignant melanoma and for prostate, head-and-neck and breast cancers.</p>
<blockquote>
<p>pathogens 病原体 </p>
<p>cytomegalovirus 巨细胞病毒 </p>
<p>immune system 免疫系统 </p>
<p>malignant melanoma 恶性黑色素瘤</p>
</blockquote>
<p>学习如何在不破坏或不刺激无益的免疫反应的情况下将mRNA引入体内一直是一项挑战。这两种新疫苗是该技术潜力的第一个证据。Moderna正在寻找信使rna作为其他疫苗的基础，这些疫苗针对巨细胞病毒、流感、儿科-呼吸-合胞病毒和寨卡病毒等病原体。与此同时，BioNTech正在探索利用mRNA来刺激免疫系统对抗癌症。该计划包括恶性黑色素瘤、前列腺癌、头颈癌和乳腺癌的治疗。</p>
<p><strong>As for</strong> covid-19, the success of these rapidly created mRNA vaccines <strong>bodes well for</strong> dealing with any future mutations of SARS-CoV-2. <strong>As the pandemic continues to spread, and such mutations accrue,</strong> <em>it is possible that</em> the excellent responses these vaccines now provoke could wane. <strong>That, though, should not be a problem.</strong> Just as natural selection can <strong>tinker with</strong> the virus’s genetic code, so too can scientists tinker with the code in the vaccines. And, once they have proved themselves, those vaccines could be adjusted every year, <strong>as happens already with</strong> influenza vaccines. <strong>The tools the world needs to emerge from</strong> the covid-19 pandemic <strong>are starting to arrive</strong>. <strong>That</strong> <em>they are all arriving at the same time</em> <strong>is an unlooked-for blessing</strong>.■</p>
<blockquote>
<p>Tinker with .. 任意更改…</p>
<p>Unlooked for 意外的</p>
<p>This success was quite unlooked for.</p>
<p>这次成功很意外。</p>
<p>They encountered unlooked-for difficulties.</p>
<p>他们遇到了始料未及的困难。</p>
</blockquote>
<p>至于covid-19，这些快速创建的mRNA疫苗的成功预示着应对未来SARS-CoV-2突变的良好前景。随着大流行的继续蔓延和这种突变的积累，这些疫苗现在所产生的极好的反应可能会减弱。不过，这应该不是问题。正如自然选择可以修改病毒的遗传密码一样，科学家也可以修改疫苗中的遗传密码。而且，一旦它们证明了自己，这些疫苗可以每年进行调整，就像流感疫苗一样。世界应对covid-19大流行所需的工具已经开始到位。他们能同时到达，真是想不到的好事。</p>

      
    </div>
    <footer class="entry-meta entry-footer">
      
      
      
        <div id="donation_div"></div>


<script src="/js/vdonate.js"></script>

<script>
var a = new Donate({
  title: '如果觉得我的文章对您有用，请随意打赏。您的支持将鼓励我继续创作!', // 可选参数，打赏标题
  btnText: 'Donate', // 可选参数，打赏按钮文字
  el: document.getElementById('donation_div'),
  wechatImage: 'https://raw.githubusercontent.com/iTimeTraveler/iTimeTraveler.github.io/site/source/about/donate/images/WeChanQR.png',
  alipayImage: 'https://raw.githubusercontent.com/iTimeTraveler/iTimeTraveler.github.io/site/source/about/donate/images/AliPayQR.jpg'
});
</script>
      
            
      
        
	<div id="comment">
		<!-- 来必力City版安装代码 -->
		<div id="lv-container" data-id="city" data-uid="MTAyMC8yOTQ4MS82MDQ5">
		<script type="text/javascript">
		   (function(d, s) {
		       var j, e = d.getElementsByTagName(s)[0];

		       if (typeof LivereTower === 'function') { return; }

		       j = d.createElement(s);
		       j.src = 'https://cdn-city.livere.com/js/embed.dist.js';
		       j.async = true;

		       e.parentNode.insertBefore(j, e);
		   })(document, 'script');
		</script>
		<noscript>为正常使用来必力评论功能请激活JavaScript</noscript>
		</div>
		<!-- City版安装代码已完成 -->
	</div>


      
    </footer>
  </div>
  
    
<nav id="article-nav">
  
    <a href="/2020/11/29/Day223-The%20Economist/" id="article-nav-newer" class="article-nav-link-wrap">
      <strong class="article-nav-caption">Newer</strong>
      <div class="article-nav-title">
        
          (no title)
        
      </div>
    </a>
  
  
    <a href="/2020/11/27/Day221-The%20Economist/" id="article-nav-older" class="article-nav-link-wrap">
      <strong class="article-nav-caption">Older</strong>
      <div class="article-nav-title"></div>
    </a>
  
</nav>

  
</article>

<!-- Table of Contents -->

  <aside id="sidebar">
    <div id="toc" class="toc-article" style="overflow-y: scroll; max-width: 28%;">
    <strong class="toc-title">Contents</strong>
    
      <ol class="nav"><li class="nav-item nav-level-1"><a class="nav-link" href="#A-second-vaccine-against-covid-19-arrives"><span class="nav-number">1.</span> <span class="nav-text">A second vaccine against covid-19 arrives</span></a><ol class="nav-child"><li class="nav-item nav-level-6"><a class="nav-link" href="#Getting-better-all-the-time-%E4%B8%80%E7%9B%B4%E5%9C%A8%E5%A5%BD%E8%BD%AC-image-20201128110012040-Users-chenyujie-Library-Application-Support-typora-user-images-image-20201128110012040-png"><span class="nav-number">1.0.0.0.0.1.</span> <span class="nav-text">Getting better all the time 一直在好转 ![image-20201128110012040](&#x2F;Users&#x2F;chenyujie&#x2F;Library&#x2F;Application Support&#x2F;typora-user-images&#x2F;image-20201128110012040.png)</span></a></li></ol></li><li class="nav-item nav-level-5"><a class="nav-link" href="#And-there-are-surely-more-to-come-%E8%82%AF%E5%AE%9A%E8%BF%98%E4%BC%9A%E6%9C%89%E6%9B%B4%E5%A4%9A"><span class="nav-number">1.0.0.0.1.</span> <span class="nav-text">And there are surely more to come 肯定还会有更多</span></a></li></ol></li></ol></li></ol></li></ol></li></ol>
    
    </div>
  </aside>
</section>
        
      </div>
      <footer id="footer" class="site-footer">
  

  <div class="clearfix container">
      <div class="site-info">
	      &copy; 2023 Hexo All Rights Reserved.
          
            <span id="busuanzi_container_site_uv">
              本站访客数<span id="busuanzi_value_site_uv"></span>人次  
              本站总访问量<span id="busuanzi_value_site_pv"></span>次
            </span>
          
      </div>
      <div class="site-credit">
        Theme by <a href="https://github.com/iTimeTraveler/hexo-theme-hiero" target="_blank">hiero</a>
      </div>
  </div>
</footer>


<!-- min height -->

<script>
    var contentdiv = document.getElementById("content");

    contentdiv.style.minHeight = document.body.offsetHeight - document.getElementById("allheader").offsetHeight - document.getElementById("footer").offsetHeight + "px";
</script>

<!-- Custome JS -->

<script src="/js/my.js"></script>

    </div>
    <!-- <nav id="mobile-nav">
  
    <a href="/" class="mobile-nav-link">Home</a>
  
    <a href="/archives" class="mobile-nav-link">Archives</a>
  
    <a href="/categories" class="mobile-nav-link">Categories</a>
  
    <a href="/tags" class="mobile-nav-link">Tags</a>
  
    <a href="/about" class="mobile-nav-link">About</a>
  
</nav> -->
    

<!-- mathjax config similar to math.stackexchange -->

<script type="text/x-mathjax-config">
  MathJax.Hub.Config({
    tex2jax: {
      inlineMath: [ ['$','$'], ["\\(","\\)"] ],
      processEscapes: true
    }
  });
</script>

<script type="text/x-mathjax-config">
    MathJax.Hub.Config({
      tex2jax: {
        skipTags: ['script', 'noscript', 'style', 'textarea', 'pre', 'code']
      }
    });
</script>

<script type="text/x-mathjax-config">
    MathJax.Hub.Queue(function() {
        var all = MathJax.Hub.getAllJax(), i;
        for(i=0; i < all.length; i += 1) {
            all[i].SourceElement().parentNode.className += ' has-jax';
        }
    });
</script>

<script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.4/MathJax.js?config=TeX-AMS-MML_HTMLorMML">
</script>



  
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/fancybox/2.1.5/jquery.fancybox.min.css">

  
<script src="https://cdnjs.cloudflare.com/ajax/libs/fancybox/2.1.5/jquery.fancybox.min.js"></script>




<script src="/js/scripts.js"></script>


<script src="https://stackpath.bootstrapcdn.com/bootstrap/3.3.7/js/bootstrap.min.js"></script>


<script src="/js/main.js"></script>








  <div style="display: none;">
    <script src="https://s95.cnzz.com/z_stat.php?id=1260716016&web_id=1260716016" language="JavaScript"></script>
  </div>



	<script async src="https://dnqof95d40fo6.cloudfront.net/atw7f8.js">
	</script>






  </div>

  <a id="rocket" href="#top" class=""></a>
  <script type="text/javascript" src="/js/totop.js" async=""></script>
</body>
</html>
